Ocular surface disease: accurately diagnose & effectively treat your surgical patients
Colin Kerr
Published: Thursday, May 31, 2018
In this supplement, published by EuroTimes in association with the ESCRS/EuCornea Education Forum, we discuss some of the hot topics in Ocular Surface Disease. The supplement includes articles by Elizabeth M Messmer, Germany, Christophe Baudouin, France, Béatrice Cochener, France and Jose M Benitez del Castillo, Spain.
The supplement is supported by an unrestricted educational grant from Shire, Novartis and TearLab.
Download Supplement - click here
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.